The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice

The role of poly(ADP-ribose) polymerase-1 (PARP-1) treatment in carrageenan-induced pleurisy in mice. •Studies the effect of PARP-1 inhibitor on carrageenan induced pleurisy.•PARP-1 inhibitor alleviated Cg-induced pleurisy.•Studied the change in T cell subsets, IL-17 and T regulatory cells.•Signific...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular immunology 2015-02, Vol.63 (2), p.394-405
Hauptverfasser: Ahmad, Sheikh Fayaz, Zoheir, Khairy M.A., Ansari, Mushtaq Ahmad, Korashy, Hesham M., Bakheet, Saleh A., Ashour, Abdelkader E., Al-Shabanah, Othman A., Al-harbi, Mohammed M., Attia, Sabry M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The role of poly(ADP-ribose) polymerase-1 (PARP-1) treatment in carrageenan-induced pleurisy in mice. •Studies the effect of PARP-1 inhibitor on carrageenan induced pleurisy.•PARP-1 inhibitor alleviated Cg-induced pleurisy.•Studied the change in T cell subsets, IL-17 and T regulatory cells.•Significant change in pro-inflammatory mediators and adhesion molecules.•Significant change in COX-2, STAT-3, NF-kB, PARP-1, IkB-α, IL-4 protein expression. Increasing indication is unveiling a role for poly(ADP-ribose) polymerase (PARP)-1 in the regulation of inflammatory/immune responses. The aim of the present study was to determine the potential anti-inflammatory effects of PARP-1 inhibitor 5-aminoisoquinolinone (5-AIQ) to explore the role of PARP-1 inhibitor in a mouse model of carrageenan-induced lung inflammation. A single dose of 5-AIQ (1.5mg/kg) was administered intraperitoneally (i.p.) 1h before λ-carrageenan (Cg) administration. We assessed the effects of 5-AIQ treatment on CD25+, GITR+, CD25+GITR+, IL-17+ and Foxp3+ cells which were investigated using flowcytometry in pleural exudates and heparinized blood. We also evaluated mRNA expressions of IL-6, TNF-α, IL-1β, IL-10, CD11a, l-selectin (CD62L), ICAM-1, MCP-1, iNOS and COX-2 in the lung tissue. We further examined the effects of 5-AIQ on the key mediators of inflammation, namely COX-2, STAT-3, NF-kB p65, PARP-1, IkB-α and IL-4 protein expression in the lung tissue using western blotting. The results illustrated that the numbers of T cell subsets, IL-17+ cytokine levels were markedly increased and Foxp3+ production decreased in the Cg group. Furthermore, Cg-induced up-regulation of adhesion molecules, pro-inflammatory mediators and chemokine expressions. Western blot analysis revealed an increased protein expressions of COX-2, STAT-3 NF-kB p65 and PARP-1 and decreased IkB-α and IL-4 in the Cg group. PARP-1 inhibitor via 5-AIQ treatment reverses the action significantly of all the previously mentioned effects. Moreover, histological examinations revealed anti-inflammatory effects of 5-AIQ, whereas Cg-group aggravated Cg-induced inflammation. Present findings demonstrate the potent anti-inflammatory action of the PARP-1 inhibitor in acute lung injury induced by carrageenan.
ISSN:0161-5890
1872-9142
DOI:10.1016/j.molimm.2014.09.009